Medical devices, healthcare technology and the business of care
510(k) clearance · K262074

Any-Zircos

Mediclus Co., Ltd. · Decision date Aug 21, 2026

FDA DECISIONK262074

What did the FDA decide?

FDA records K262074 as a 510(k) premarket notification, with a decision dated Aug 21, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Aug 21, 2026

FDA source record

Regulatory record facts

Identifier
K262074
Regulatory pathway
510(k) premarket notification
Product code
EIH
Decision code
SESE
Decision date
Aug 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Powder, Porcelain.

Product code
EIH
FDA device class
2

FDA decision timeline

  1. K262074 received

    Application receipt date recorded by FDA.

  2. K262074 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code EIH

Product / regulatory recordCompanyPathwayDecision dateSource
Zirconia Collective, Inc.510(k) clearanceOct 30, 2026FDA
Fanen New Materials Technology (Suzhou) Co., Ltd.510(k) clearanceOct 29, 2026FDA
DentMedi Co., Ltd.510(k) clearanceOct 21, 2026FDA
Amber ArteK262523
Hass Corp.510(k) clearanceOct 16, 2026FDA
Prismatik Dentalcraft, Inc.510(k) clearanceJul 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mediclus Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cheongju-Si

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records